Search

everythinglearnresearchcommunity

for

Search:↓

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Finasteride can cause sexual problems and depression in young men.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Consider benefits and risks of new alopecia treatments for safety.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

A new mutation in the STS gene causes X-linked ichthyosis, even in rare female cases.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

The report suggests that the same underlying issue in blood vessel support may cause angiokeratomas on both the scrotum and eyelids.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

A new mutation in the DCAF17 gene was found in a Chinese family, causing Woodhouse-Sakati syndrome and diabetes.